Market closedNon-fractional
Edwards Lifesciences/EW
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Edwards Lifesciences
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Ticker
EW
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Irvine, United States
Employees
19,800
Website
www.edwards.com
EW Metrics
BasicAdvanced
$36B
Market cap
24.55
P/E ratio
$2.43
EPS
1.11
Beta
-
Dividend rate
Price and volume
Market cap
$36B
Beta
1.11
Financial strength
Current ratio
3.711
Quick ratio
2.321
Long term debt to equity
8.948
Total debt to equity
9.234
Interest coverage (TTM)
106.63%
Management effectiveness
Return on assets (TTM)
12.28%
Return on equity (TTM)
22.02%
Valuation
Price to earnings (TTM)
24.551
Price to revenue (TTM)
5.812
Price to book
4.83
Price to tangible book (TTM)
6.12
Growth
Revenue change (TTM)
9.67%
Earnings per share change (TTM)
7.56%
3-year revenue growth (CAGR)
8.00%
3-year earnings per share growth (CAGR)
1.81%
What the Analysts think about EW
Analyst Ratings
Majority rating from 32 analysts.
EW Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.6B
4.18%
Net income
$352M
-4.87%
Profit margin
22.01%
-8.71%
EW Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.66
$0.59
$0.64
$0.66
-
Expected
$0.65
$0.59
$0.64
$0.64
$0.69
Surprise
2.03%
-0.40%
0.41%
2.68%
-
EW News
AllArticlesVideos
Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Seeking Alpha·13 hours ago
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
Accesswire·13 hours ago
S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product
Investopedia·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Edwards Lifesciences stock?
Edwards Lifesciences (EW) has a market cap of $36B as of July 27, 2024.
What is the P/E ratio for Edwards Lifesciences stock?
The price to earnings (P/E) ratio for Edwards Lifesciences (EW) stock is 24.55 as of July 27, 2024.
Does Edwards Lifesciences stock pay dividends?
No, Edwards Lifesciences (EW) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Edwards Lifesciences dividend payment date?
Edwards Lifesciences (EW) stock does not pay dividends to its shareholders.
What is the beta indicator for Edwards Lifesciences?
Edwards Lifesciences (EW) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Edwards Lifesciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.